 VANCOUVER, Wash., Sept. 13, 2021 GLOBE NEWSWIRE -- Absci Corporation Nasdaq: ABSI, the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BofA Securities 2021 Tech Solutions for Drug Discovery Conference. 